- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Intercept Pharmaceuticals Inc+ Add to Watchlist
ICPT:US237.650 USD 8.160 3.56%
As of 17:20:00 ET on 10/24/2014.
Company Profile for Intercept Pharmaceuticals Inc (ICPT)
Intercept Pharmaceuticals, Inc. manufactures and markets biopharmaceutical products. The Company focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. Intercept Pharmaceuticals serves customers throughout the United States.
Intercept Pharmaceuticals Inc
Key Executives for Intercept Pharmaceuticals Inc (ICPT)
|Mark PruzanskiPresident/CEO/Co-Founder||Barbara DuncanCFO/Treasurer/Secretary|
|Daniel P ReganChief Commercial Officer||Rachel L McMinnChief Strategy Officer|
|Luciano AdoriniChief Scientific Officer||David ShapiroExec VP:Dev/Chief Medical Ofcr|